TipRanks on MSN

Polaris Industries’ Promising Study on ADI-PEG 20 for Liver Cancer

Polaris Industries (($PII)) announced an update on their ongoing clinical study. Study Overview: Polaris Industries is conducting a study titled A ...
TipRanks on MSN

Polaris Group’s Phase 3 Trial for Leiomyosarcoma: A Potential Game-Changer

Polaris Industries (($PII)) announced an update on their ongoing clinical study. Study Overview: Polaris Group is conducting a Phase 3 clinical ...

Polaris (PII) Gets a Hold from Roth MKM

Roth MKM analyst Scott Stember maintained a Hold rating on Polaris today and set a price target of $54.00. The company’s shares closed yesterday at $71.19. Elevate Your Investin ...

REPEAT/StratifAI Joins With MSK iHub Challenge Cohort to Advance Validation of Polaris Through Access to World-Class Clinical Datasets

StratifAI, the AI precision oncology company behind the Polaris platform, today announced its selection for the Memorial Sloan Kettering (MSK) iHub Challenge 2025 Cohort program. This engagement will ...
Business Wire

Hippocratic AI Releases Polaris 3.0: A 4.2 Trillion Parameter Suite of 22 LLMs, Enhancing Patient Safety and Experience By Leveraging Real-World Experiences

Enhancements in clinical documentation, emotional quotient, audio handling, multilingual safety, orchestration, dialer, and integration features combined with advanced deep-thinking models to create a ...

Polaris Inc: Q3 Earnings Snapshot

MEDINA, Minn. (AP) — MEDINA, Minn. (AP) — Polaris Inc. (PII) on Tuesday reported a loss of $15.8 million in its third quarter. On a per-share basis, the Medina, Minnesota-based company said it had a ...